Opioids for the management of breakthrough (episodic) pain in cancer patients-Reference-Cited by-同舟云学术

Opioids for the management of breakthrough (episodic) pain in cancer patients

Published:2006-01-25 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Zeppetella Giovambattista,Ribeiro Maria DC

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004311.pub2/epdf/full

Reference27 articles.

1. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain;Christie;Journal of Clinical Oncology,1998

2. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR);Coluzzi;Douleurs,2002

3. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR);Coluzzi;Pain,2001

4. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients;Farrar;Journal of the National Cancer Institute,1998

5. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study;Portenoy;Pain,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the Spanish Version of the Breakthrough Pain Assessment Tool in Patients With Cancer;Cureus;2024-09-10

2. Estudio observacional, prospectivo y multicéntrico sobre el uso de citrato de fentanilo transmucosa en la práctica clínica habitual para el control de las crisis de dolor irruptivo en pacientes oncológicos;Revista de la Sociedad Española del Dolor;2023

3. Analgetika;Arzneimitteltherapie in der Palliativmedizin;2022

4. Narcotic Use for Acute Postoperative Pain Management in Mohs Micrographic Surgery Patients With End Stage Renal Disease: A Review of the Literature;Dermatologic Surgery;2021-02-22

5. A randomized, double‐blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids;European Journal of Pain;2020-03-04